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25-hydroxyvitamin D insufficiency in 
children with newly diagnosed asthma
ABSTRACT
Background. 25-hydroxyvitamin D [25(OH)D] deficiency seems to be related to the development of asthma. 
Any evaluation of the relationship between asthma and 25(OH)D deficiency must consider the association 
between increased airway responsiveness, eosinophil counts and serum immunoglobulin E (IgE), and 
25(OH)D as a potential player in airway remodelling. 
Objective. We assessed the association of 25(OH)D with markers of atopy and eosinophilic inflammation 
in children with newly diagnosed asthma. 
Methods. The study included 165 children aged 2–12 years. The diagnosis of asthma was performed by 
an experienced paediatric pulmonologist. Allergic asthma was diagnosed in 106 children, and non-allergic 
asthma in ten; in 49 children, asthma was excluded. Fasting blood was collected for cell counts, and serum 
was obtained to measure lipids, C-reactive protein (hsCRP), 25(OH)D and IgE. 
Results. Children with asthma had significantly lower 25(OH)D (p < 0.001). Both groups had similar lipid 
values. Elevated total IgE concentration and eosinophil counts were found in asthmatics; neutrophils were 
similar in asthmatic and reference groups. There was a strong tendency to higher eosinophil counts in 
25(OH)D-deficient children (< 20 ng/mL) with atopic asthma (p < 0.08).
Conclusion. In children with asthma, 25(OH)D insufficiency/deficiency is associated with higher eosinophil 
counts and IgE. 25(OH)D monitoring is important in the prevention and management of children with asthma.
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Introduction
In recent years, a significant rise in the prevalence 
of childhood asthma has been widely observed [1]. 
Bronchial asthma is a chronic inflammatory disorder 
of the airways that is related to their hyperresponsive-
ness and remodelling, both contributing to variable 
degrees of airflow obstruction [1]. The common host 
and environmental factors that affect the development 
and expression of asthma in children include the expo-
sure to allergens and respiratory infections, chemical 
irritants and drugs, changes in lifestyle conditions, 
e.g. dietary habits, high prevalence of vitamin D 
insufficiency/ deficiency, and decreased outdoor and 
indoor physical activity leading to excessive body 
weight [1–4].
Asthma is a heterogeneous disease with multiple, 
overlapping phenotypes. The primary classification 
of the disease into immunoglobulin E (IgE)-mediated 
allergic asthma and non-IgE-mediated non-allergic 
asthma has recently been extended [5, 6]. A major role 
is played by T helper type 2 (Th2) cells that mediate 
airway allergic inflammation by increased production 
of proinflammatory cytokines [interleukin-4 (IL-4), 
interleukin-5 (IL-5), interleukin-13 (IL-13)], of which 
IL-4 and interleukin-13 (IL-13) are related to increased 
IgE concentrations [4]. Several clinical asthma phe-
notypes have been distinguished, including cellular 
and molecular phenotypes [5]. Cellular phenotypes 
differ according to the distribution of eosinophils and 
neutrophils in the sputum of asthma patients, whereas 
molecular phenotypes vary according to the overex-
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pression of specific factors such as periostin, serpin 
peptidase inhibitor-B2 (SerpinB2), Transforming Growth 
Factor-b2 (TGF-b2), Vascular Endothelial Growth Factor 
(VEGF) and others [5, 7]. Asthmatic patients are hetero-
geneous on the molecular level: those with high Th2 re-
sponse may have a higher airway hyperresponsiveness, 
higher blood eosinophil count, higher serum IgE and bio-
markers of airway remodelling, and benefit from different 
types of treatment, whereas these with low Th2 response 
and neutrophilia are more resistant to treatment [6, 8, 9]. 
Biomarkers are currently being investigated to more 
effectively characterise the disease phenotypes and to 
identify the responders to specific targeted therapies. Very 
recently, blood eosinophilia and fractional exhaled nitric 
oxide (FeNO) have been described as potential surrogate 
markers associated with distinct asthma phenotypes 
related to Th2-driven inflammation [5]. 
Vitamin D, due to its immunomodulatory properties, 
exerts actions on the cells of innate and adaptive immune 
system functions; it may be associated with respiratory 
infections and possibly with airway remodelling. In ep-
idemiological studies, 25-hydroxyvitamin D [25(OH)D] 
deficiency has been suggested as being related to the 
development of asthma and the frequency of asthma 
symptoms [10–12]. Vitamin D deficiency may weaken 
pulmonary defences against respiratory infections, and 
this would contribute to the triggering of asthma exacer-
bations. In an observational study, 25(OH)D insufficiency 
was shown to be associated with an increased risk of 
asthma exacerbation in children [13]. The role of vitamin D 
as a predictor of atopy and asthma associated-pheno-
types has also been investigated in children [14]. 
An evaluation of the relationship between asthma 
and vitamin D deficiency must take into consideration 
aspects such as the association with increased airway 
responsiveness, higher eosinophil count and serum 
IgE levels, and the potential role of 25(OH)D in airway 
remodelling. The available data strongly suggests an 
independent association between vitamin D deficiency 
and asthma [15–18]. In view of the widespread 25(OH)D 
insufficiency/ deficiency [14, 19], we aimed to elucidate 
the possible association of serum 25-hydroxyvitamin D 
level with traditional and novel markers of atopy and 
eosinophilic inflammation in children with newly diag-
nosed asthma. 
Methods
Study participants 
The study included 165 children aged 2–12 years 
referred to the Outpatient Clinic at the Department of 
Paediatrics, Pneumonology and Allergology of the 
Children’s Hospital (Bydgoszcz, Warsaw, Poland) due 
to asthma-like symptoms and who agreed to participate 
in the study. Written informed parental consent for each 
participant was obtained, and the study protocol was 
approved by the Bioethics Committee at the Collegium 
Medicum of the Nicolaus Copernicus University. The 
diagnosis or exclusion of asthma was performed by 
an experienced paediatric pulmonologist on the basis 
of the patient’s clinical symptoms and medical history 
according to the Global Initiative for Asthma (GINA) [20]; 
in children < 5 years, the diagnosis was based on family 
history and clinical symptoms; additional tests such as 
skin tests and/or total IgE/specific IgE measurement 
and AP Index were performed. In children > 5 years, 
the diagnosis was based on the medical history, clin-
ical symptoms and spirometry, if necessary. None of 
the children included in the study received any addi-
tional vitamin D supplementation beyond their regular 
dietary intake.
Allergic asthma was diagnosed in 106 children, and 
non-allergic asthma in ten; in 49 children, asthma was 
excluded. The latter group was considered the reference 
group. In all subjects, anthropometric measurements 
were performed and body mass index (BMI) was cal-
culated. Overweight or obesity were considered on the 
basis of BMI-for-age percentiles for girls or boys [21]. 
Children with BMI values between 85th–95th percen-
tiles were considered overweight, while these with 
BMI > 95th percentile were considered obese. 
Sample collection and laboratory measurements
In all subjects, fasting blood was collected in the 
early morning (7.00–9.00 am). Blood cell count was 
performed and serum was obtained within less than one 
hour and stored deep-frozen (–80°C) in small aliquots 
until assayed within eight months. Serum was assayed 
for total cholesterol (TC), low-density lipoprotein-cho-
lesterol (LDL-C), high-density lipoprotein-cholesterol 
(HDL-C), triglycerides (TG), and high-sensitivity C-reac-
tive protein (hs CRP), (PENTRA 400, Horiba ABX, Mont-
pellier, France). Serum 25(OH)D total (EIA, ids-isys, 
IDS Ltd, Boldon, UK), total IgE and specific IgE (Immu-
noCap-100, Phadia AB, Uppsala, Sweden) were also 
determined. 
25-hydroxy Vitamin D EIA test kit is aligned to the 
ID-LC-/MS/MS Reference Measurement Proce-
dure. The detection limit for 25(OH)D total was 
2.5 ng/mL(5 nmol/L). Antibodies used in this assay 
cross-reacted with 25(OH)D3 in 100%, with 25(OH)D2 
in 75%, with 24,25(OH)2D3 in > 100%. Blood cell count 
was performed with the use of a haematology analyser 
Sysmex XE-2100 (Sysmex Corporation, Kobe, Kansai, 
Japan).
We accepted the following cut-off values for nor-
mal lipids and hsCRP: TC ≤ 170 mg/dL (4.4 mmol/L), 
HDL-C ≥ 45 mg/dL (1.16 mmo/L), LDL-C ≤ 110 mg/dL 
(2.85 mmol/L), TG ≤ 75 mg/dL up to 9 years of age 
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(0.85 mm/L), ≤ 90 mg/dL from 10 years of age (1.02 mmol/L), 
hsCRP ≤ 1mg/L [22]. Serum 25(OH)D total concentra-
tion ≥ 30 ng/mL (≥ 75 nmol/L) was accepted as sufficient, 
21–29 ng/mL as insufficient, and ≤ 20 ng/mL (≤ 50 nmol/L) 
as deficient according to the recommendations for the 
Polish population [19]. The cut-offs for total IgE (kU/L) 
were accepted in reference to age according to the 
manufacturer’s recommendations. The following cut-
offs for blood eosinophil values were used: less than 
300 cells/μL to define normal values, 300–500 cells/μL 
for intermediate, and > 500 cells/μL for high values 
(eosinophilia). The normal range for neutrophil count 
was accepted as 1.5–8.0 × 103/μL. 
Statistical analysis
We used descriptive statistics to obtain the charac-
teristics of the study and reference groups. Continuous 
variables were expressed as mean ± standard deviation 
(Gaussian distribution) and median with 25th and 75th per-
centiles (non-Gaussian distribution). Data was compared 
using the Student-t test for normally distributed variables 
and the Mann-Whitney-U-test for non-normally distrib-
uted variables. Natural-log transformed total IgE was 
used for comparisons. The Spearman correlation was 
used to analyse the associations between variables. A p 
value < 0.05 was considered statistically significant. 
The statistical analysis was performed using Statistica 
10.0 for Windows (StatSoft, Tulsa, OK, USA) and Med-
Calc 12.7.0 (MedCalc Software, Ostend, Belgium).
Results
The demographic and biochemical characteristics 
of the study participants are presented in Table 1. Chil-
dren with asthma had significantly lower 25(OH)D. 
Both groups had similar median age and BMI, yet the 
proportion of overweight and obesity was significantly 
higher in the asthma group. The same median lipid 
values were observed in both groups, although the 
percentage of hypertriglyceridemia was higher in the 
reference group. Median CRP was only slightly higher 
in children with asthma, but we observed a significantly 
higher proportion of children with elevated CRP. Sub-
stantially elevated total IgE (log10 IgE) concentration 
and eosinophil count were other characteristic features 
in children with asthma. Neutrophil counts were not 
significantly higher in asthmatics. 
Mean concentration of 25(OH)D in children with 
asthma was 27.9 ± 8.4 ng/mL, and was within the 
range of insufficiency (21–29 ng/mL). 60.7% of children 
with asthma were found to be insufficient or deficient, 
with the level below the accepted sufficient cut-off of 
30 ng/mL, 19.1% were deficient with serum 25(OH)D 
levels ≤ 20 ng/mL, and 6.4% were severely deficient 
(≤ 15 ng/mL). In the reference group, only 2.1% were 
severely deficient. The proportion of 25(OH)D insuffi-
cient and deficient subjects was considerably higher in 
asthmatics than in the reference group (Tab. 1).
The number of children with non-atopic asthma 
was very small (ten cases), which made it reasonable 
to perform further analysis only in the group diagnosed 
with atopic asthma. Very similar results were observed 
in subjects with atopic asthma (n = 106) compared to 
the reference group. The average 25(OH)D concentra-
tion was lower (28 ± 8.3 vs 33.8 ± 12.7; p = 0.002) 
but the eosinophil count (290/μL vs 140/μL; p < 0.001) 
and the total IgE (log IgE 2.10 ± 0.80 vs 1.18 ± 0.56; 
p < 0.000001) were considerably higher in subjects with 
atopic asthma. The proportion of children with atopic 
asthma, 25(OH)D insufficient and deficient, was 63.5% 
compared to 40.4% in the reference group.
Table 2 presents a  comparison of selected bio-
chemical and anthropometric indices in relation to 
25(OH)D concentration in children with atopic asthma. 
Interestingly, we found that eosinophil counts showed 
a strong tendency to higher values in 25(OH)D-deficient 
children with atopic asthma (p < 0.080). Also neutrophil 
counts were slightly higher in 25(OH)D-deficient atopic 
asthma children. A weak but significant inverse correla-
tion of 25(OH)D with neutrophil count was observed 
(R = –0.288; p = 0.011). Moreover, in asthmatic children, 
a tendency to higher CRP at lower vitamin D concen-
trations was found (R = –0.216; p = 0.067). It is worth 
noting that 25(OH)D did not correlate with serum IgE .
25(OH)D concentration may depend on the season, 
but we found that the average 25(OH)D in samples 
collected between May and September and between 
October and April did not differ in these small children 
(in children with asthma 28.3 vs 27.9 ng/mL; p = 0.85 in 
summer vs winter, or in the reference group 35.3 vs 
32.5 ng/mL; p = 0.46 in summer vs winter). 
Discussion
Several recent studies on 25(OH)D level in children 
with asthma have revealed that more than half of them 
were vitamin D insufficient or deficient [16, 17, 23, 24]. In 
our study, the majority of children with newly diagnosed 
asthma had significantly lower concentration of serum 
25(OH)D compared to the reference group. Even at this 
early age (2–12 years), 25(OH)D concentrations were 
below the recommended value of 30 ng/mL in more than 
three out of five (63.5%) children with atopic asthma. In 
subjects without an asthma diagnosis, the prevalence 
of insufficiency or deficiency was much lower (40.4%). 
The proportion of severely deficient (≤ 15 ng/mL) was 
three-fold higher in asthmatics than in the reference 
group (6.4 vs 2.1%). This is not surprising, as according 
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Table 1. Biochemical and clinical characteristics of study participants
Asthma (n = 116) Reference group (n = 49) P value
Gender M /F (%) 53.4/ 46.6 57.1/42.9 0.600
Age (years) 5.0 (4.0–7.0) 5.0 (4.0–7.0) 0.174
BMI [kg/m2] 15.9 (15.0–17.0) 15.8 (14.8–17.1) 0.664
25(OH)D [ng/mL] 27.9 ± 8.4 33.8 ± 12.7 0.001
Log total IgE kU/L 2.05 ± 0.73 1.18 ± 0.56 0.000001
Eosinophil count [cells/μL] 290 (160–440) 140 (90–290) 0.001
Neutrophil count [103/μL] 3.77 (2.75–4.56) 3.13 (2.31–4.42) 0.127
hsCRP [mg/L] 0.32 (0.10–0.70) 0.18 (0.07–0.65) 0.220
Overweight/obesity (%) 9.0/11.2 4.1/2.0 0.05/0.04
25(OH)D ≤ 20 ng/mL (%) 19.1 12.8 0.090
25(OH)D < 30 ng/mL (%) 60.7 40.4 0.050
TC > 170 mg/dL (%) 46.1 51.0 0.390
LDL-C > 110 mg/dL (%) 33.7 36.7 0.210
HDL-C < 45 mg/dL (%) 21.3 18.4 0.866
Hypertriglyceridemia (%) 28.1 42.9 0.060
hsCRP > 3 mg/L (%) 10.1 6.1 0.050
Eosinophil count > 300 cells/μL (%) 47.7 21.7 0.030
Eosinophil count > 500 cells/μL (%) 20.9 4.3 0.020
BMI — body mass index; 25(OH)D — 25-hydroxyvitamin D; IgE — immunoglobulin E; hsCRP — high-sensitivity C-reactive protein; TC — total 
cholesterol; LDL-C — low-density lipoprotein cholesterol; HDL-C — high-density lipoprotein cholesterol
Table 2. Comparison of selected biochemical and anthropometric indices in relation to 25(OH)D concentration in 
children with atopic asthma
25(OH)D deficiency (10–20 ng/mL) 25(OH)D > 20 ng/mL P value
Age (years) 6.5 (5.0–9.0) 5.0 (4.0–7.0) 0.095
BMI [kg/m2] 15.5 (14.5–15.8) 16.1 (15.0–17.1) 0.043
25(OH)D [ng/mL] 17.3 ± 2.4 30.3 ± 7.3 0.001
hsCRP [mg/L] 0.43 (0.24–2.32) 0.27 (0.10–0.70) 0.190
Eosinophil count [cells/μL] 320 (120–540) 280 (160–430) 0.080
Neutrophil count [× 103/μL] 4.58 (3.37–5.62) 3.64 (2.59–4.29) 0.087
Log total IgE [kU/L] 2.37 ± 0.46 2.05 ± 0.77 0.172
25(OH)D — 25-hydroxyvitamin D; BMI — body mass index; hsCRP — high-sensitivity C-reactive protein; IgE — immunoglobulin
to recent epidemiological data on vitamin D deficiency 
(≤ 20 ng/mL) in the Polish population, 35% of children 
aged 2–4 years and 80% of those aged 5–11 years are 
vitamin D deficient [19]. 
The high proportion of 25(OH)D insufficiency or de-
ficiency may have implications pertaining to changes in 
lung function, because in early childhood the respirato-
ry system is particularly sensitive to environmental and 
nutritional influences [24]. Data from epidemiological 
studies has shown that low serum 25-hydroxyvita -
min D concentration is associated with a higher risk 
of upper and lower respiratory infections in children 
and may contribute to asthmatic patients’ symptoms 
and morbidity rates [14, 16, 25]. 25(OH)D insufficien-
cy may be considered as an important aspect in the 
onset of childhood atopy and food allergies. A report 
from Australia showed that low 25-hydroxyvitamin D 
concentration in boys at age 6 predicted atopy or asth-
ma at age 14 [14]. 
The relationship between vitamin D insufficiency/de-
ficiency and asthma may be affected by factors such as 
ethnicity and socioeconomic status. In Costa Rican chil-
dren, 25(OH)D deficiency was related to increased air-
way responsiveness and higher biomarkers of asthma 
and atopy, such as eosinophil count and IgE levels [11]. 
On the other hand, a very recent study performed on 
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a population of Asian children and adolescents aged 
5–18 years provided epidemiological evidence against 
the association of serum 25(OH)D status with con-
current asthma, atopy and serum total IgE [26]. The 
authors noted, however, that the role of serum 25(OH)
D as a predictor of subsequent asthma remains to be 
defined. Nevertheless, it seems that it is not yet clear 
whether vitamin D level is critical in asthma onset, and 
more studies in this field are needed. 
The important role of vitamin D in asthma patho-
genesis, based on modulation of T cell driven immune 
responses, has been extensively studied. The inhibitory 
effect of 1.25 (OH)2D on Th1 cells’ cytokine production 
seems to be evident but the effect on Th2 response 
remains to be explained further [16]. Asthma is a hetero-
geneous disease with multiple subtypes. One of them is 
characterised by higher blood eosinophil count, higher 
serum IgE and biomarkers of airway remodelling, and 
shows better responsiveness to treatment, particularly 
with corticosteroids [6–9, 27]. 
We demonstrated that children diagnosed with atop-
ic asthma with 25(OH)D deficiency presented a strong 
tendency to higher eosinophil counts. Like others, we 
used blood eosinophil count to quantify eosinophilic 
inflammation as this method is simple, non-invasive 
and economical, even though it does not anatomically 
localise inflammation. In our study, almost half of the 
children with asthma presented with elevated blood 
eosinophil count (> 300 cells/μL), and 21% presented 
with eosinophilia. The association of 25(OH)D insuffi-
ciency/deficiency in asthmatic patients with high eosin-
ophils and total IgE observed in our study may suggest 
an effect of inflammation on circulating 25(OH)D. 
Whether vitamin D could have a role in the preven-
tion and treatment of asthma, allergic diseases and 
respiratory infections in childhood, and whether it rep-
resents a novel preventive and/or therapeutic strategy 
still remains to be elucidated. For this purpose, well 
designed clinical trials on vitamin D supplementation 
with the right dose are necessary. 
Our study was an observational study and included 
a limited number of participants. However, our group 
of asthmatic subjects was well defined, and our study 
and reference groups were age- and gender-matched. 
Our conclusion is valid for children with allergic asthma. 
We conclude that in children with asthma, 25(OH)D 
insufficiency/deficiency is associated with higher 
eosinophil counts and IgE. 25(OH)D monitoring is im-
portant in the prevention and management of children 
with asthma.
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